PNC-27
A synthetic membrane-translocating peptide designed for the study of targeted cancer cell lysis via p53-activation pathways.
PNC-27 is an innovative research peptide containing a specialized p53-binding domain coupled with a cell-penetrating sequence. It is investigated for its ability to target HDM2-overexpressing cancer cell lines and induce selective cell lysis.
Scientific Reference Library
Research: The anti-cancer peptide PNC-27 induces tumor cell necrosis by targeting membrane-bound HDM2
Link: https://pubmed.ncbi.nlm.nih.gov/20433286/
Research: Specific membrane poration of cancer cell lines by p53-derived synthetic peptides
€ 150.00
